STATE STREET CORP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$38,501,953
-28.5%
12,665,116
-22.6%
0.00%
-33.3%
Q2 2023$53,818,248
-4.7%
16,358,130
-7.9%
0.00%0.0%
Q1 2023$56,494,436
-68.0%
17,765,546
-30.4%
0.00%
-40.0%
Q4 2022$176,591,078
+119.3%
25,518,942
+100.6%
0.01%0.0%
Q3 2022$80,521,000
+965.7%
12,720,480
+597.0%
0.01%
Q2 2022$7,556,000
-88.2%
1,825,101
-86.1%
0.00%
-100.0%
Q1 2022$63,787,000
-16.2%
13,151,891
+72.7%
0.00%
-25.0%
Q4 2021$76,097,000
-10.9%
7,617,310
+70.4%
0.00%
-20.0%
Q3 2021$85,420,000
-2.5%
4,469,936
+63.1%
0.01%0.0%
Q2 2021$87,646,000
+20.0%
2,740,662
+13.2%
0.01%
+25.0%
Q1 2021$73,016,000
-26.3%
2,421,753
+5.7%
0.00%
-33.3%
Q4 2020$99,126,000
+6.7%
2,290,862
+33.0%
0.01%0.0%
Q3 2020$92,925,000
-7.3%
1,722,422
+4.9%
0.01%
-14.3%
Q2 2020$100,257,000
+41.5%
1,642,482
+6.5%
0.01%
+16.7%
Q1 2020$70,869,000
-46.9%
1,541,969
+1.4%
0.01%
-33.3%
Q4 2019$133,488,000
+11.5%
1,521,230
+16.6%
0.01%0.0%
Q3 2019$119,755,000
-19.8%
1,304,238
+11.1%
0.01%
-18.2%
Q2 2019$149,266,000
-18.4%
1,173,473
+1.0%
0.01%
-21.4%
Q1 2019$182,855,000
+58.9%
1,162,241
+0.2%
0.01%
+40.0%
Q4 2018$115,061,000
-28.9%
1,159,886
+4.7%
0.01%
-16.7%
Q3 2018$161,761,000
+5.6%
1,107,976
+13.5%
0.01%
-7.7%
Q2 2018$153,181,000
-29.0%
975,963
-22.8%
0.01%
-27.8%
Q1 2018$215,819,000
-8.3%
1,263,972
-4.4%
0.02%
-5.3%
Q4 2017$235,370,000
+15.0%
1,321,553
-11.3%
0.02%
+5.6%
Q3 2017$204,669,000
+33.8%
1,490,128
+2.3%
0.02%
+28.6%
Q2 2017$152,972,000
+4.5%
1,456,088
-9.6%
0.01%
+7.7%
Q1 2017$146,443,000
+52.8%
1,611,032
+3.7%
0.01%
+44.4%
Q4 2016$95,814,000
-14.8%
1,552,804
-6.4%
0.01%
-18.2%
Q3 2016$112,485,000
+52.8%
1,659,517
-2.4%
0.01%
+37.5%
Q2 2016$73,592,000
+44.0%
1,699,977
+41.4%
0.01%
+33.3%
Q1 2016$51,088,000
-16.7%
1,201,936
+25.9%
0.01%
-14.3%
Q4 2015$61,310,000
+16.2%
954,682
+54.7%
0.01%
+16.7%
Q3 2015$52,782,000
-33.2%
616,940
+31.4%
0.01%
-25.0%
Q2 2015$79,058,000
+10.1%
469,538
-21.0%
0.01%
+14.3%
Q1 2015$71,819,000
+43.8%
594,657
+9.2%
0.01%
+40.0%
Q4 2014$49,947,000
+87.5%
544,555
-26.7%
0.01%
+66.7%
Q3 2014$26,644,000
+175.6%
742,590
+196.3%
0.00%
+200.0%
Q2 2014$9,668,000
+370.7%
250,626
+177.6%
0.00%
Q1 2014$2,054,000
+29.9%
90,291
+19.6%
0.00%
Q4 2013$1,581,000
+3.1%
75,468
+32.8%
0.00%
Q3 2013$1,533,00056,8370.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,550,000$7,518,0001.50%
Birchview Capital, LP 84,000$407,0000.29%
PDT Partners, LLC 519,485$2,520,0000.22%
OCCUDO QUANTITATIVE STRATEGIES LP 320,922$1,556,0000.13%
Virtus ETF Advisers LLC 40,607$197,0000.09%
Baker Brothers Advisors 2,499,715$12,124,0000.07%
Green Alpha Advisors, LLC 14,660$71,0000.05%
Quinn Opportunity Partners LLC 140,824$683,0000.03%
Rafferty Asset Management, LLC 979,122$4,749,0000.03%
Inspire Investing, LLC 48,724$236,0000.03%
View complete list of BLUEBIRD BIO INC shareholders